NASDAQ NMS - GLOBAL MARKET · EIKN
+1.21% · +$0.1382 · Vol Not reported
Pre-market · updated 05:41:04 ET
Eikon Therapeutics Inc

Eikon Therapeutics Inc

Biotechnology
$11.53
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
EIKN
Eikon Therapeutics Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

58/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is EIKN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading EIKN catalysts
About Eikon Therapeutics Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2026
Employees
384
Country
US

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$11.39
Last session
Day high
$11.39
Last session
Day low
$11.39
Last session
Previous close
$11.39
52W high
$16.26
-29.10% from high
52W low
$8.36
40% of range
Market cap
$616.9M
EPS
$-8.1800
Beta
1.71
Shares out
54.2M
Avg volume
389.8K
VWAP
$11.39
Last session
Price history computed in-house
1W
+10.11%
1M
+29.53%
3M
+16.45%
SMA 50 $10.23 · above
SMA 200 Not reported · Not reported
52W position 40%

EIKN overview

Veridion Score
58
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around EIKN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading EIKN Form 4 filings
Public disclosures

Congress activity in EIKN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for EIKN in the cached public ledger.

Federal contracts

EIKN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for EIKN in this window.
Lobbying spend

EIKN lobbying filings, year to date.

Registered lobbying filings matched to Eikon Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for EIKN in this window.
Loading news for EIKN
Analyst ratings
Sovereign unlock shows live analyst consensus for EIKN.
Options
Sovereign unlock shows live options positioning for EIKN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.